PCP. Clausen

P. Clausen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


P. Clausen has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Bo Feldt-Rasmussen

    Department of Nephrology, Copenhagen University Hospital, Rigshospitalet, Copenhagen

    4 shared publications
  • G Jensen

    2 shared publications
  • G. Jensen

    From the Department of Nephrology and Endocrinology, State University Hospital, Copenhagen (P.C., B.F.-R.), and the Copenhagen City Heart Study, Epidemiological Research Unit, Bispebjerg Municipal Hospital, the University of Copenhagen (J.S.J., G.J., K.B.-J.), Denmark

    2 shared publications
  • J S Jensen

    2 shared publications
  • J. S. Jensen

    From the Department of Nephrology and Endocrinology, State University Hospital, Copenhagen (P.C., B.F.-R.), and the Copenhagen City Heart Study, Epidemiological Research Unit, Bispebjerg Municipal Hospital, the University of Copenhagen (J.S.J., G.J., K.B.-J.), Denmark

    2 shared publications
  • K Borch-Johnsen

    2 shared publications

Latest Publications

  • Elevated Urinary Albumin Excretion Is Associated With Impaired Arterial Dilatory Capacity in Clinically Healthy Subjects

    by P. Clausen, J. S. Jensen, G. Jensen, K. Borch-Johnsen, B. Feldt-Rasmussen

    Background —Elevated urinary albumin excretion (UAE) predicts atherosclerotic cardiovascular disease. It is hypothesized that elevated UAE is associated with a generalized vascular dysfunction. This study tested this hypothesis for conduit arteries. Methods and Results —Clinically healthy subjects were selected: 19 with UAE >90th percentile in the background population (6.6 μg/minP P Conclusions —Slightly elevated UAE is associated with impaired conduit arterial dilatory capacity in clinically healthy subjects, and this impairment may be explained by a reduced dilatory response to nitric oxide of both endogenous and exogenous origin. Impaired arterial dilatory capacity may contribute to the increased cardiovascular risk in subjects with elevated UAE.


  • Plasma concentrations of VCAM‐1 and ICAM‐1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy

    by P. Clausen, P. Jacobsen, K. Rossing, J. S. Jensen, H. ‐H. Parving, B. Feldt‐Rasmussen

    SUMMARY Aims  Elevated urinary albumin excretion is associated with macrovascular atherosclerotic complications in Type 1 diabetes mellitus. Adhesion molecules mediate leucocyte adhesion to the endothelium early in the atherosclerotic process. The present study tests the hypothesis that microalbuminuria and diabetic nephropathy are associated with elevated plasma concentrations of soluble vascular adhesion molecule (sVCAM)‐1, soluble intercellular adhesion molecule (sICAM)‐1, and soluble E‐selectin (sE‐selectin) aiming to illustrate factors of potential pathogenetic relevance for the excess cardiovascular disease in diabetic patients with renal complications.Methods  Soluble adhesion molecule concentrations were measured by enzyme‐linked immunosorbent assays (ELISA) in healthy controls (n = 16) and in 59 Type 1 diabetic patients: group 1 – patients with normoalbuminuria (n = 16); group 2 – patients with microalbuminuria (n = 15); group 3 – patients with macroalbuminuria and normal serum creatinine (n = 15), group 4 – patients with macroalbuminuria and moderately elevated serum creatinine (n = 13).Results  Plasma concentrations of sVCAM‐1 and sICAM‐1 were similar in healthy controls and normoalbuminuric Type 1 diabetic patients, but the concentrations were increased by the presence of microalbuminuria and overt nephropathy (P < 0.001 and P < 0.0001, anova). Concentrations of sE‐selectin did not differ between diabetic patients and controls.Conclusions  Plasma concentration of sICAM‐1 is elevated in Type 1 diabetic patients with microalbuminuria and the concentrations of sICAM‐1 as well as sVCAM‐1 are elevated in patients with macroalbuminuria and normal s‐creatinine. The elevated plasma concentrations of these soluble adhesion molecule concentrations in patients with renal complication can be of pathogenetic importance for the development of atherosclerosis and plasma soluble adhesion molecule concentrations may provide additional information on cardiovascular risk.


  • Elevated Urinary Albumin Excretion is not Linked to the Angiotensin I-converting Enzyme Gene Polymorphism in Clinically Healthy Subjects

    by P Clausen, J S Jensen, K Borch-Johnsen, G Jensen, B Feldt-Rasmussen

    An elevated urinary albumin excretion (UAE) in non-diabetic subjects without renal or cardiovascular disease has been shown to be predictive of ischaemic heart disease. An insertion (I)/deletion (D) polymorphism in the angiotensin I-converting enzyme (ACE) gene has been identified and the D allele may be associated with cardiovascular disease. The aim of this study was to find a potential linkage between this polymorphism and elevated UAE. For studies of UAE and cardiovascular pathophysiology, a highly selected population sample has been identified comprising all clinically healthy subjects aged 40-65 years with elevated UAE in a dipstick negative urinary sample (n = 27) from The Copenhagen City Heart Study. Neither the ACE genotype distribution (p = 0.12) nor the D and I allele frequencies (p = 0.69) differed significantly between subjects with elevated UAE and a matched normoalbuminuric control group (n = 46). Elevated UAE in clinically healthy subjects is not linked to the ACE gene polymorphism.


  • Plasma concentrations of endothelial vasoactive substances in clinically healthy subjects. Associations with urinary albumin excretion and ambulatory blood pressure

    by P. Clausen, J. Skov Jensen, G. Jensen, B. Feldt–Rasmussen

    Elevated urinary albumin excretion (UAE) is a predictor of cardiovascular disease, and one possible explanation is that elevated UAE reflects a generalized vascular dysfunction. The present study tests whether the plasma concentrations of the two main endothelial vasoactive substances (nitric oxide and endothelin-1 [ET-1]) are changed in clinically healthy subjects with elevated UAE (>6.6 microg/ min-the 90th percentile in the background population) and to test associations between these concentrations and systemic blood pressure. Twenty-seven subjects with elevated UAE were compared with 46 matched controls with normoalbuminuria. Plasma concentration of ET-1 was measured using an ELISA method and plasma concentration of nitrate/nitrite using a photometric method. Twenty-four-hour blood pressure was measured using a portable recorder (TM-2421). No significant differences in the concentrations of nitrate/nitrite and ET-1 were found between the groups, e.g. 21 (10-105) vs. 18 (11 -152) (p=0.33) and 0.98 (0.58 1.95) vs. 1.10 (0.54 -1.50) (p = 0.27), respectively. However, plasma nitrate/nitrite was significantly positively correlated to systolic and diastolic blood pressure in subjects with normoalbuminuria but not in subjects with elevated UAE. In contrast, plasma ET-1 concentration was significantly positively correlated to systolic blood pressure only in subjects with elevated UAE. In conclusion, elevated UAE is not associated with changed plasma concentrations of endothelial vasoactive substances in clinically healthy subjects. However, nitrate/nitrite is positively correlated to BP only in subjects with normoalbuminuria, and ET-1 is positively correlated to BP only in subjects with elevated UAE.

    • 1 January 1997
      • p. 6-9

    Detecting microalbuminuria by urinary albumin/creatinine concentration ratio.

    by J S Jensen, P Clausen, K Borch-Johnsen, G Jensen, B Feldt-Rasmussen

    Microalbuminuria, i.e. a subclinical increase of the albumin excretion rate in urine, may be a novel atherosclerotic risk factor. This study aimed to test whether microalbuminuria can be identified by measurement of urinary albumin concentration or urinary albumin/creatinine concentration ratio, instead of the usual measurement of the albumin excretion rate in a timed urine collection. All 2579 subjects analysed were screened in a population based epidemiological study. Participants with diabetes mellitus, renal disease, haematuria, or urinary tract infection were not included. Urinary albumin (Ualb) and creatinine (Ucreat) concentrations were measured in an overnight collected sample by enzyme-linked immunosorbent and colorimetric assays, respectively. Urinary albumin excretion rate (UAER) and urinary albumin/creatinine concentration ratio (Ualb/Ucreat) were calculated. The correlation between Ualb and UAER was 0.72 (n = 2579, P < 0.001), and the correlation between Ualb/Ucreat and UAER was 0.81 (n = 2579, P < 0.001). In the detection of microalbuminuria, the nosographic sensitivity and specificity, and the diagnostic specificity were 58%, 97%, and 66% for Ualb, and 73%, 97%, and 73% for Ualb/Ucreat, respectively. It is concluded that measurement of the albumin/creatinine concentration ratio is a specific and quite sensitive alternative to measurement of the urinary albumin excretion rate in timed collections, when screening for microalbuminuria.